Concord Drugs Standalone September 2021 Net Sales at Rs 9.86 crore, down 40.49% Y-o-Y

October 20, 2021 / 01:18 PM IST

live

bselive
nselive

Volume

Todays L/H

Reported Standalone quarterly numbers for Concord Drugs are:

Net Sales at Rs 9.86 crore in September 2021 down 40.49% from Rs. 16.57 crore in September 2020.

Quarterly Net Profit at Rs. 0.46 crore in September 2021 up 467.69% from Rs. 0.08 crore in September 2020.

EBITDA stands at Rs. 1.67 crore in September 2021 up 79.57% from Rs. 0.93 crore in September 2020.

Concord Drugs EPS has increased to Rs. 0.52 in September 2021 from Rs. 0.09 in September 2020.

Concord Drugs shares closed at 33.10 on October 19, 2021 (BSE) and has given -15.02% returns over the last 6 months and 29.55% over the last 12 months.

Concord Drugs
Standalone Quarterly Results	in Rs. Cr.

	Sep'21	Jun'21	Sep'20
Net Sales/Income from operations	9.83	20.22	16.57
Other Operating Income	0.03	--	--
Total Income From Operations	9.86	20.22	16.57
EXPENDITURE
Consumption of Raw Materials	7.43	15.66	13.84
Purchase of Traded Goods	--	--	--
Increase/Decrease in Stocks	-0.72	0.18	0.27
Power & Fuel	--	--	--
Employees Cost	1.04	1.05	1.01
Depreciation	0.57	0.53	0.33
Excise Duty	--	--	--
Admin. And Selling Expenses	--	--	--
R & D Expenses	--	--	--
Provisions And Contingencies	--	--	--
Exp. Capitalised	--	--	--
Other Expenses	0.45	1.05	0.56
P/L Before Other Inc. , Int., Excpt. Items & Tax	1.10	1.74	0.55
Other Income	--	0.02	0.04
P/L Before Int., Excpt. Items & Tax	1.10	1.76	0.60
Interest	0.31	0.96	0.49
P/L Before Exceptional Items & Tax	0.79	0.80	0.11
Exceptional Items	--	--	--
P/L Before Tax	0.79	0.80	0.11
Tax	0.34	0.11	0.03
P/L After Tax from Ordinary Activities	0.46	0.69	0.08
Prior Year Adjustments	--	--	--
Extra Ordinary Items	--	--	--
Net Profit/(Loss) For the Period	0.46	0.69	0.08
Equity Share Capital	8.74	8.74	8.74
Reserves Excluding Revaluation Reserves	19.17	--	--
Equity Dividend Rate (%)	--	--	--
EPS Before Extra Ordinary
Basic EPS	0.52	0.79	0.09
Diluted EPS	0.52	0.79	0.09
EPS After Extra Ordinary
Basic EPS	0.52	0.79	0.09
Diluted EPS	0.52	0.79	0.09
Public Share Holding
No Of Shares (Crores)	--	--	--
Share Holding (%)	--	--	--
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
b) Non-encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
Source : Dion Global Solutions Limited